Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI.

Boll Chim Farm. 1998 Jul-Aug;137(7):267-76. Unique Identifier : AIDSLINE MED/99011574
Vigorita MG; Ottana R; Maccari R; Monforte F; Bisignano G; Pizzimenti FC; Dipartimento Farmaco-chimico, Universita di Messina, Italy.


Abstract: Various kinds of lipophilic analogues of isonicotinic acid hydrazide (Isoniazid) were synthesized and in vitro explored in a search for antimycobacterial agents with extended activity spectrum against pathogens responsible for the AIDS-associated diseases. The primary in vitro screening showed that a) isonicotinoylhydrazones 1a, 1b, 1d, 1e are more active than the parent drug against non-tubercular mycobacteria (MIC ranging between 0.5 and 4 micrograms/ml), b) isonicotinohydrazides 6b and 6e display interesting antibacterial activity on some Gram + and Gram-strains, and c) trifluoromethyl-containing compounds 1a and 2c inhibit the growth of several human tumor cell lines at doses between 10(-5) and 10(-6) M. On the contrary, none of the tested analogues significantly counteracts the cytopathogenicity induced by HIV and HSV viruses.
Keywords: JOURNAL ARTICLE Anti-Infective Agents/*CHEMICAL SYNTHESIS/PHARMACOLOGY Antineoplastic Agents/*CHEMICAL SYNTHESIS/PHARMACOLOGY Drug Screening Assays, Antitumor Human Isoniazid/*ANALOGS & DERIVATIVES Microbial Sensitivity Tests Mycobacterium/DRUG EFFECTS Support, Non-U.S. Gov't Tumor Cells, CulturedKWDjournalarticleanti-infectiveagents/KWDchemicalsynthesis/pharmacologyantineoplasticagents/KWDchemicalsynthesis/pharmacologydrugscreeningassays,antitumorhumanisoniazid/KWDanalogs&derivativesmicrobialsensitivitytestsmycobacterium/drugeffectssupport,non-uKWDsKWDgov'ttumorcells,cultured
990228
A9920932

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .